Black Diamond Therapeutics, Inc vs Pfizer, Inc. — Stock Comparison
Black Diamond Therapeutics, Inc (BDTX) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Pfizer, Inc. narrowly edges Black Diamond Therapeutics, Inc on Q·Score (6.4 vs 6 out of 10), led by Quality (6.4 vs 1.6) and Valuation (7.7 vs 6.3). Black Diamond Therapeutics, Inc scores higher on Health, reflecting stronger balance sheet strength. Analyst consensus targets imply greater upside for BDTX (+493.8%) than for PFE (+15.8%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Clean balance sheet with low leverage (0.2× debt-to-equity).
⚠ low return on equity (-35%).
Forward P/E of 8.9× is low relative to sector peers.
⚠ earnings contracting 10% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
BDTX vs PFE: which stock scores better overall?
Based on Q·Score, Pfizer, Inc. (PFE) scores 6.4/10 versus Black Diamond Therapeutics, Inc (BDTX) at 6/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: BDTX or PFE?
Black Diamond Therapeutics, Inc (BDTX) scores higher on Growth (6.3/10 vs 5.1/10). Black Diamond Therapeutics, Inc reports revenue growth while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is BDTX or PFE more attractively valued?
Pfizer, Inc. (PFE) scores higher on Valuation (7.7/10 vs 6.3/10). Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about BDTX vs PFE?
There are 7 analysts covering BDTX with a consensus price target of $9.86, and 27 analysts covering PFE with a consensus target of $29.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: BDTX or PFE?
Pfizer, Inc. (PFE) scores higher on Quality (6.4/10 vs 1.6/10). Net profit margin: BDTX at 0.0%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: BDTX or PFE?
Black Diamond Therapeutics, Inc (BDTX) scores higher on Financial Health (9.7/10 vs 7/10). Market beta: BDTX at 3.23, PFE at 0.29. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of BDTX and PFE?
Black Diamond Therapeutics, Inc (BDTX) has a market capitalisation of $95M, while Pfizer, Inc. (PFE) has a market cap of $143.7B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do BDTX or PFE pay dividends?
BDTX does not currently pay a dividend, while PFE pays a dividend yield of 6.61%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →